Tumor-Associated Macrophages as Key Modulators of Disease Progression in Diffuse Large B-Cell Lymphoma
With the advent of new therapeutic approaches, there is hope that anticancer treatment will eventually be possible without the use of chemotherapy. Efficient immunotherapeutic options have recently emerged in many cancers, offering a less aggressive approach, with overall better tolerance, making th...
Saved in:
| Main Authors: | Corina Joldes, Laura Jimbu, Oana Mesaros, Mihnea Zdrenghea, Bogdan Fetica |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/5/1099 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinicopathological value of tumor-associated macrophages in adult classical Hodgkin lymphoma in Hawler city
by: Tenya Tariq Abdulhameed, et al.
Published: (2025-04-01) -
Prognostic significance of CD163- and CD68-expressing macrophages in nodular sclerosis Hodgkin lymphoma
by: E. A. Perfilova, et al.
Published: (2022-01-01) -
Renal Involvement in Diffuse Large B-cell Lymphoma
by: Shashikant Saini, et al.
Published: (2024-10-01) -
Breast Diffuse Large B-cell Lymphoma, Activated B-cell like Subtype: A Case Report
by: Sneha Samir Babaria, et al.
Published: (2025-01-01) -
Tumor-Associated Macrophages: Polarization, Immunoregulation, and Immunotherapy
by: Abdullah Farhan Saeed
Published: (2025-05-01)